OSTX OS Therapies Incorporated

XASE
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

OSTX — —

What changed

Recent filings, trades and moves
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XASE
Market Cap
$0.0B
Employees
5
List Date
2024-08-01
CIK
0001795091
Last Earnings
Aug 19
Headquarters
Rockville, MD
Homepage
https://www.ostherapies.com

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conju…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Markers: Click a marker type to show or hide it. Earnings turn amber when the stock moved more than options implied; hollow markers are still to come, or insider trades under a 10b5-1 plan. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'24'25'26Avg
Jan---55.98%1.49%-27.24%
Feb---5.71%5.76%0.02%
Mar--6.94%-1.40%2.77%
Apr--52.63%25.00%38.81%
May---20.73%32.92%6.10%
Jun--20.51%1.60%11.06%
Jul---7.77%-16.71%-12.24%
Aug64.94%36.57%9.03%36.85%
Sep-29.29%-11.71%-3.61%-14.87%
Oct-8.71%-7.00%-22.98%-12.90%
Nov-18.63%-4.28%-30.98%*-17.96%
Dec91.93%-18.13%--36.90%
Total66.28%-47.55%-16.87%0.62%
* Only 3 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.01
SMA 50: $1.35
SMA 200: $1.53
Current: $0.78
EMA 12: $0.88
EMA 26: $1.05
MACD: -0.1689 | Signal: -0.0050
BEARISH
ADX (14): 45.56
STRONG TREND
+DI: 14.57
−DI: 31.88

Momentum Oscillators

RSI (14): 33.18
NEUTRAL
Stoch %K: 32.38
Stoch %D: 26.36
Williams %R: -72.06

Volume & Volatility

BB Upper: $1.42
BB Lower: $0.61
NEUTRAL
OBV: 30,196,874
Vol SMA 20: 750,227
Vol ROC: -87.93%
ATR: $0.13
True Range: $0.16
HV 20: 138.6%
HV 30: 115.4%
HV 60: 92.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-20T00:00:00 – 2026-11-18T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

OSTX Options Activity & IV Rank

Loading options activity...
Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
ATM — / Put —
30 DTE / 10d put —
— pts EXTREME
ATM — / Put —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 1.6722
Alpha: -55.90%
Correlation: 0.2809
R-Squared: 7.9%
Stock Volatility: 82.2%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own OSTX
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Rockefeller Capital Management Family office
Rockefeller family
$12K
0.00%
#4102 of 48580.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

OSTX Institutional Ownership (13F)

Filings for 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

29 filers2,610,608 shares$4.32M value
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 777,651 $1.24M 28.82% — 2026-09-30
2 Geode Capital Management, LLC Custodian 370,948 $593.52K 13.75% — 2026-09-30
3 HOWARD FINANCIAL SERVICES, LTD. 248,001 $471.20K 10.91% — 2026-06-30
4 BlackRock, Inc. Custodian 245,147 $392.24K 9.08% — 2026-09-30
5 Vanguard Fiduciary Trust Co 222,768 $356.43K 8.26% — 2026-09-30
6 State Street Corp 155,800 $249.28K 5.77% — 2026-09-30
7 HighTower Advisors, LLC 91,650 $146.64K 3.40% — 2026-09-30
8 Northern Trust Corp Custodian 70,817 $134.55K 3.12% — 2026-06-30
9 Beacon Pointe Advisors, LLC 62,507 $118.76K 2.75% — 2026-06-30
10 BRIDGEWAY CAPITAL MANAGEMENT, LLC 45,000 $85.50K 1.98% — 2026-06-30
11 Empowered Funds, LLC Custodian 44,238 $70.78K 1.64% — 2026-09-30
12 HRT FINANCIAL LP 40,217 $64.00K 1.48% — 2026-09-30
13 INGALLS & SNYDER LLC 36,676 $59.00K 1.37% — 2026-09-30
14 Two Sigma Investments, LP Custodian 30,414 $57.79K 1.34% — 2026-06-30
15 Stifel Financial Corp Custodian 27,900 $44.64K 1.03% — 2026-09-30
16 Stratos Wealth Advisors, LLC 21,314 $34.10K 0.79% — 2026-09-30
17 Vanguard Global Advisers, LLC 20,958 $33.53K 0.78% — 2026-09-30
18 SANDERS MORRIS HARRIS LLC 20,000 $32.00K 0.74% — 2026-09-30
19 Susquehanna International Group, LLP Custodian 13,532 $25.71K 0.60% — 2026-06-30
20 StoneX Group Inc. 14,853 $22.58K 0.52% — 2026-09-30
21 Jones Financial Companies LLLP Custodian 13,299 $22.08K 0.51% — 2026-09-30
22 Morgan Stanley Custodian 13,000 $20.80K 0.48% — 2026-09-30
23 UBS Group AG Custodian 12,806 $20.49K 0.47% — 2026-09-30
24 Rockefeller Capital Management L.P. Custodian 7,500 $12.00K 0.28% — 2026-09-30
25 Nuveen, LLC Custodian 1,794 $2.89K 0.07% — 2026-09-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

OSTX Insider Trading (Form 4)

Latest: 2026-11-12
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-11-12 Kerry M Clem Chief Commercial Officer Award (A) +200,000 — EDGAR
2026-11-12 Knuettel Francis II Chief Financial Officer Award (A) +250,000 — EDGAR
2026-10-30 Knuettel Francis II Chief Financial Officer Award (A) — — EDGAR
2026-10-30 Olivier Roger Jarry Director Grant (A) +300,000 opt — EDGAR
2026-10-30 Paul A. Romness President and CEO Award (A) — — EDGAR
2026-10-30 Craig Eagle Director Grant (A) +300,000 opt — EDGAR
2026-10-30 Theodore F. Search Director Award (A) — — EDGAR
2026-10-30 Robert Petit See Remarks Award (A) — — EDGAR
2026-10-30 Avril Suzette McKean-Dieser Director Award (A) — — EDGAR
2026-10-30 John Ciccio Director Award (A) — — EDGAR
2026-10-30 Kerry M Clem Chief Commercial Officer Award (A) — — EDGAR
2026-02-13 Olivier Roger Jarry Director Grant (A) +50,000 opt — EDGAR
2026-02-13 Robert Petit See Remarks Award (A) — — EDGAR
2026-02-13 Karim Galzahr Director Grant (A) +50,000 opt — EDGAR
2026-02-13 Paul A. Romness President and CEO Award (A) — — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

OSTX Insider Holdings

10 insiders · @ $0.78
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Shalom Auerbach 10%+ Owner 2,769,570 $2.16M -$365.9K 3 2025-04-11
2 Einodmil LLC 10%+ Owner 2,687,570 $2.10M -$276.5K 3 2025-05-09
3 Paul A. Romness President and CEO 2,473,000 $1.93M $0 5 2026-10-30
4 John Ciccio Director 455,835 $356.1K $0 4 2026-10-30
5 Theodore F. Search Director 455,835 $356.1K $0 4 2026-10-30
6 Knuettel Francis II Chief Financial Officer 270,000 $210.9K $0 2 2026-11-12
7 Kerry M Clem Chief Commercial Officer 225,000 $175.7K $0 2 2026-11-12
8 Robert Petit See Remarks 200,000 $156.2K $0 3 2026-10-30
9 Christopher P. Acevedo Chief Financial Officer 109,375 $85.4K $0 2 2026-02-13
10 Avril Suzette McKean-Dieser Director 5,000 $3.9K $0 3 2026-10-30
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

OSTX Board & Officers

As of SEC filings through Nov 12, 2026

Directors 6

Officers 4

Changes in the last 10 years (24)
Sep 29, 2026The company announced the departure of Christopher P. Acevedo as Chief Financial Officer in an SEC filing
Sep 29, 2026Knuettel Francis II became Chief Financial Officer
Sep 29, 2026Kerry M Clem became Chief Commercial Officer
Jul 1, 2026Craig Eagle became a director
Jun 1, 2026The company announced the departure of Karim Galzahr from the board in an SEC filing
Dec 19, 2025Paul A. Romness no longer listed as a 10% owner in SEC filings
May 9, 2025Shalom Auerbach reported in an SEC filing no longer being a 10% owner
May 9, 2025Einodmil LLC reported in an SEC filing no longer being a 10% owner
Jan 28, 2025Karim Galzahr became a director
Oct 28, 2024The company announced the departure of Joacim Borg from the board in an SEC filing
Oct 28, 2024The company announced the departure of Colin Goddard from the board in an SEC filing
Oct 28, 2024Olivier Roger Jarry became a director
Oct 28, 2024Avril Suzette McKean-Dieser became a director
Jul 31, 2024Theodore F. Search became a director
Jul 31, 2024Shalom Auerbach became a 10% owner
Jul 31, 2024Robert Petit became an officer
Jul 31, 2024Paul A. Romness became a director
Jul 31, 2024Paul A. Romness became a 10% owner
Jul 31, 2024Paul A. Romness became President and CEO
Jul 31, 2024John Ciccio became a director
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

OSTX Proposed Insider Sales (Form 144)

Latest: 2025-05-07
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-05-07 Einodmil LLC 10% stockholder 1,200,000 $2.81M 2025-05-07 Pershing LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-16
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-12 Other events EDGAR
2026-10-19 Material agreement · Unregistered share sale · Other events EDGAR
2026-10-05 Material agreement · Director or officer change · Other events EDGAR
2026-09-10 Other events EDGAR
2026-09-09 Director or officer change · Shareholder vote results EDGAR
2026-08-21 Material agreement EDGAR
2026-08-12 Material agreement · New debt obligation · Unregistered share sale EDGAR
2026-08-06 Material agreement · New debt obligation · Unregistered share sale EDGAR
2026-07-29 Agreement terminated EDGAR
2026-07-02 Material agreement · New debt obligation · Unregistered share sale · Director or officer change · Other events EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-16 0001213900-26-120639 EDGAR
2026-08-14 0001213900-26-090238 EDGAR
ETF Holders
3 ETFs hold OSTX
3 shown · $935.67K total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXF Vanguard Extended Market ETF Vanguard 0.00% $448,305 — 2026-10-31
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $406,612 — 2026-10-31
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $80,751 $1.2B 2026-11-17
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

OSTX vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
LLY Eli Lilly & Co. $1.23T 44.0 +45.5% +25.6% 34
JNJ Johnson & Johnson $656.5B 40.4 +7.8% +28.5% 86
ABBV ABBVIE INC. $505.6B 48.7 +10.7% +23.5% 50
MRK Merck & Co., Inc. $339.7B 136.5 +4.9% +24.4% 60
NVS Novartis AG $293.1B — — +9.4% 31
AZN AstraZeneca PLC $277.2B — — +91.3% 24
ABT Abbott Laboratories $181.0B 38.5 +10.0% −16.3% 29
NVO Novo-Nordisk A/S $173.8B — — −25.9% 26
OSTX OS Therapies Incorporated $48M — — −41.7% —
Peer median $316.4B 44.0 +10.0% +23.9% 32

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.